| Serial Number | 88570483 |
| Word Mark | X PARSOLEX PARTNER SOLUTIONS EXCELLENCE |
| Filing Date | Wednesday, August 7, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 18, 2021 |
| Registration Number | 6356727 |
| Registration Date | Tuesday, May 18, 2021 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 28, 2020 |
| Description of Mark | The mark consists of a stylized design comprised of two diagonal intersecting pill capsules forming a heart shaped arrow design on the left side and creating an "x" shape; the design element appears to the left of the wording "Parsolex"; centered underneath the design and "Parsolex" wording appears the wording "PARTNER SOLUTIONS EXCELLENCE". |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "SOLUTIONS" |
| Goods and Services | Consulting services in the fields of pharmaceutical, medical and healthcare research and development; technical services, namely, research and development in the pharmaceutical and biotechnology fields; consulting services for pharmaceutical formulation design, design of processes to transform inorganic and organic substances and pharmaceutical technology transfer being advice and information about pharmaceutical research and design; technical services, namely, providing advice, information and instructions for pharmaceutical formulation design and design of processes to transform inorganic and organic substances, pharmaceutical technology transfer being advice and information about pharmaceutical research and design; pharmaceutical product chemical and physical evaluation services, namely, test method development, test method validation, use of test methods for in-process control, quality control, and product release, and technology transfer being advice and information about pharmaceutical test methods; analytical chemistry services, namely, developing and validating test methods for drug product release; technology transfer being advice and information about the drug product testing process and test methods; providing services to others in the fields of analytical, chemistry and manufacturing controls for the production and regulatory approval of pharmaceuticals, namely, providing scientific information relating to the analysis and management of the pharmaceutical manufacturing process for the production, packaging, and regulatory approval of pharmaceuticals; consulting services in the fields of chemistry, biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; consulting and research and development services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; technical consulting in the fields of pharmaceutical studies, research and development; technical consulting in the field of pharmaceutical development and engineering; technical consulting in the field of analytical chemistry services; consultancy pertaining to pharmacology; technology consultation in the fields of research and development of pharmaceuticals, medicines and healthcare products; scientific research consulting in the fields of pharmaceuticals, medicines and healthcare products; product development consulting in the fields of pharmaceuticals, medicines and healthcare products; scientific research services relating to pharmaceuticals, medicines and healthcare products; product development consultation; product development services; formulation and process design services for drug products for others; outsource service provider for manufacturing and packaging of pharmaceuticals; formulation and process design services for drug products for others; design of packaging for pharmaceuticals of others; pharmaceutical product packaging design services for others; formulation and process design services for drug products of others; provision of information, advice and consultancy in relation to pharmaceutical packaging design; technical consulting in the field of pharmaceutical research and development; custom pharmaceutical service provider, namely, pharmaceutical formulation design, design of processes to transform inorganic and organic substances, and chemical and physical evaluation of pharmaceuticals; consulting in the areas of pharmaceutical formulation design, design of processes to transform inorganic and organic substances, and chemical and physical evaluation of pharmaceuticals; development of custom pharmaceuticals for others; design of packaging for pharmaceuticals for others; formulation and process design services for drug products for others |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, August 24, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, October 28, 2019 |
| First Use In Commerce Date | Monday, October 28, 2019 |
| Party Name | Parsolex GMP Center, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | West Lafayette, IN 47906 |
| Party Name | Parsolex GMP Center, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | West Lafayette, IN 47906 |
| Party Name | Parsolex GMP Center, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | West Lafayette, IN 47906 |
| Event Date | Event Description |
| Tuesday, May 18, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Friday, April 16, 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, April 15, 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, April 2, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, March 17, 2021 | USE AMENDMENT FILED |
| Thursday, April 1, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, March 17, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, September 22, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 28, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 28, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 8, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 24, 2020 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, June 16, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 16, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, June 16, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 16, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 16, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 16, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, June 15, 2020 | WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST |
| Tuesday, May 26, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 26, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 6, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 22, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 22, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, April 22, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 22, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 22, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, April 16, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 16, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 15, 2020 | ASSIGNED TO LIE |
| Wednesday, April 8, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 31, 2019 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Thursday, October 31, 2019 | PRIORITY ACTION E-MAILED |
| Thursday, October 31, 2019 | PRIORITY ACTION WRITTEN |
| Wednesday, October 16, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, August 27, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, August 24, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, August 10, 2019 | NEW APPLICATION ENTERED |